Delivery Devices Crucial To Success, Lifespan Of Asthma/COPD Meds
This article was originally published in The Gray Sheet
Executive Summary
Sales of Merck’s Singulair fell off the molecular patent cliff, but not Glaxo’s still-mighty Advair. Why? Because it has an additional patent protecting its delivery device.